AU5123396A - Pharmaceutical composition containing sucralfate - Google Patents

Pharmaceutical composition containing sucralfate

Info

Publication number
AU5123396A
AU5123396A AU51233/96A AU5123396A AU5123396A AU 5123396 A AU5123396 A AU 5123396A AU 51233/96 A AU51233/96 A AU 51233/96A AU 5123396 A AU5123396 A AU 5123396A AU 5123396 A AU5123396 A AU 5123396A
Authority
AU
Australia
Prior art keywords
pharmaceutical composition
composition containing
containing sucralfate
sucralfate
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU51233/96A
Inventor
Shoichi Higo
Kazuo Igusa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of AU5123396A publication Critical patent/AU5123396A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
AU51233/96A 1995-04-03 1996-04-02 Pharmaceutical composition containing sucralfate Abandoned AU5123396A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP7778195 1995-04-03
JP7-77781 1995-04-03
PCT/JP1996/000891 WO1996031218A1 (en) 1995-04-03 1996-04-02 Pharmaceutical composition containing sucralfate

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU11353/00A Division AU746091B2 (en) 1995-04-03 2000-01-14 Sucralfate containing pharmaceutical composition

Publications (1)

Publication Number Publication Date
AU5123396A true AU5123396A (en) 1996-10-23

Family

ID=13643518

Family Applications (1)

Application Number Title Priority Date Filing Date
AU51233/96A Abandoned AU5123396A (en) 1995-04-03 1996-04-02 Pharmaceutical composition containing sucralfate

Country Status (8)

Country Link
US (1) US5985843A (en)
EP (1) EP0823255A4 (en)
KR (1) KR19980703526A (en)
CN (1) CN1183044A (en)
AU (1) AU5123396A (en)
CA (1) CA2217233A1 (en)
TR (1) TR199701092T1 (en)
WO (1) WO1996031218A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698210A (en) 1995-03-17 1997-12-16 Lee County Mosquito Control District Controlled delivery compositions and processes for treating organisms in a column of water or on land
AU746091B2 (en) * 1995-04-03 2002-04-18 Chugai Seiyaku Kabushiki Kaisha Sucralfate containing pharmaceutical composition
US6077539A (en) 1996-11-12 2000-06-20 Pozen, Inc. Treatment of migraine headache
US6761895B2 (en) 2000-04-17 2004-07-13 Yamanouchi Pharmaceutical Co., Ltd. Drug delivery system for averting pharmacokinetic drug interaction and method thereof
AU2001250646A1 (en) * 2000-04-17 2001-10-30 Yamanouchi Pharmaceutical Co..Ltd. Drug delivery system for avoiding pharmacokinetic interaction between drugs and method thereof
WO2002064120A1 (en) * 2001-02-13 2002-08-22 Taisho Pharmaceutical Co., Ltd. Gel preparations for internal use
FR2822378A1 (en) * 2001-03-23 2002-09-27 Igen Ipsor Generiques New preparation method of two layer tablets comprises separate compression of two powders, one giving instant liberation and the other giving prolonged liberation of active material, e.g. nicardipine for the treatment of hypertension
US7985422B2 (en) * 2002-08-05 2011-07-26 Torrent Pharmaceuticals Limited Dosage form
US20050137262A1 (en) * 2003-12-22 2005-06-23 Hu Patrick C. Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses
KR100582347B1 (en) * 2004-12-30 2006-05-22 한미약품 주식회사 Complex composition of 3-hydroxy-3-methyl glutaryl coa reductase inhibitor and antihypertensive agent, and process for preparing same
US20060183725A1 (en) * 2005-02-15 2006-08-17 Thomas Graeser Pharmaceutical preparation for oral contraception
US20100297224A1 (en) * 2006-08-31 2010-11-25 Horizon Therapeutics, Inc. NSAID Dose Unit Formulations with H2-Receptor Antagonists and Methods of Use
MX2010010280A (en) * 2008-03-21 2010-12-15 Mylan Pharmaceuticals Inc Extended release forumulation containing a wax.
WO2010014952A2 (en) * 2008-07-31 2010-02-04 Clarke Mosquito Control Products, Inc. Extended release tablet and method for making and using same
ES2575860T3 (en) * 2010-07-09 2016-07-01 Bhv Pharma, Inc. Combined immediate / delayed release delivery system for short half-life pharmaceutical products that include remogliflozin
MX2013001278A (en) * 2013-01-31 2014-07-30 Miguel Ángel García Pérez Pharmaceutical composition comprising a biphasic immediate-release system for controlling convulsive seizures and pain.
GR1008308B (en) 2013-05-31 2014-10-02 UNI-PHARMA ΚΛΕΩΝ ΤΣΕΤΗΣ ΦΑΡΜΑΚΕΥΤΙΚΑ ΕΡΓΑΣΤΗΡΙΑ ΑΒΕΕ με δ.τ. "UNI-PHARMA ABEE", Local pharmaceutical and medi-tech compositions containing combinations of sucralfat, hyaluronic acid, arginine and one natural moistening factor

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2347531A1 (en) * 1973-09-21 1975-04-30 Hoechst Ag MEDICINAL PREPARATIONS FOR ORAL DIABETES TREATMENT
JPS5978116A (en) * 1982-10-27 1984-05-04 Chugai Pharmaceut Co Ltd Pharmaceutical preparation of sucralfate
CA1218601A (en) * 1983-09-02 1987-03-03 Angel B. Casillan Sucralfate suspension
IT1201136B (en) * 1987-01-13 1989-01-27 Resa Farma TABLET FOR PHARMACEUTICAL USE SUITABLE FOR THE RELEASE OF SUBSTANCES OF ACTIVE SUBSTANCES
CN1053570C (en) * 1987-10-07 2000-06-21 默尔多药物公司 Pharmaceutical composition for piperidinoalkanol-decongestant combination
US5032406A (en) * 1989-02-21 1991-07-16 Norwich Eaton Pharmaceuticals, Inc. Dual-action tablet
EP0403048A3 (en) * 1989-06-14 1991-01-30 Warner-Lambert Company Medicated compositions containing sucralfate and processes for their production
EP0490920B1 (en) * 1989-09-07 1993-12-08 Gergely, Gerhard, Dr. Pharmaceutical preparation binding with gastric acid
DK469989D0 (en) * 1989-09-22 1989-09-22 Bukh Meditec PHARMACEUTICAL PREPARATION
US5013557A (en) * 1989-10-03 1991-05-07 Warner-Lambert Company Taste masking compositions comprising spray dried microcapsules containing sucralfate and methods for preparing same
FR2655266B1 (en) * 1989-12-05 1992-04-03 Smith Kline French Lab CIMETIDINE PHARMACEUTICAL COMPOSITIONS.
GB9025710D0 (en) * 1990-11-27 1991-01-09 Beecham Group Plc Novel treatment
EP0569534B1 (en) * 1991-01-30 1994-09-28 Alza Corporation Osmotic device for delayed delivery of agent
PL170554B1 (en) * 1991-12-17 1996-12-31 Fuisz Technologies Ltd Method of obtaining an anti-ulcerous composition
IT1255522B (en) * 1992-09-24 1995-11-09 Ubaldo Conte COMPRESSED FOR THERAPEUTIC USE SUITABLE FOR SELLING ONE OR MORE ACTIVE SUBSTANCES WITH DIFFERENT SPEEDS
AU7322394A (en) * 1993-07-06 1995-02-06 Mcneil-Ppc, Inc. H2 antagonist-sucralfate-antiflatulent combinations
US5593696A (en) * 1994-11-21 1997-01-14 Mcneil-Ppc, Inc. Stabilized composition of famotidine and sucralfate for treatment of gastrointestinal disorders

Also Published As

Publication number Publication date
EP0823255A4 (en) 1999-01-27
CN1183044A (en) 1998-05-27
TR199701092T1 (en) 1998-01-21
WO1996031218A1 (en) 1996-10-10
EP0823255A1 (en) 1998-02-11
KR19980703526A (en) 1998-11-05
CA2217233A1 (en) 1996-10-10
US5985843A (en) 1999-11-16

Similar Documents

Publication Publication Date Title
HUP9802999A3 (en) Pharmaceutical composition containing n-propargyl-1-aminoindan
AU6216296A (en) Pharmaceutical compositions
HUP9602056A3 (en) Novel pharmaceutical composition containing phenofibrate
HU9601698D0 (en) Pharmaceutical composition
AUPN411195A0 (en) Medicinal composition
AU7590096A (en) Drug composition
AU6418596A (en) Compounds and pharmaceutical compositions containing them
AU5123396A (en) Pharmaceutical composition containing sucralfate
AU5155096A (en) Pharmaceutical composition
GB9519667D0 (en) Pharmaceutical composition
AU7904998A (en) Pharmaceutical composition containing peptichemio
AU5274096A (en) Pharmaceutical compositions
AU2531295A (en) Pharmaceutical composition
AU689366B2 (en) Sucralfate preparation
GB9502695D0 (en) Pharmaceutical composition
ZA9610426B (en) Pharmaceutical composition
AU1172097A (en) Pharmaceutical composition containing trehalose
AU3710695A (en) Quinolonylcarboxyerythromycin derivatives and pharmaceutical compositions containing them
AU6814496A (en) Pharmaceutical composition
AU723097C (en) Pharmaceutical composition
AU741226C (en) Pharmaceutical composition
AUPN060495A0 (en) Pharmaceutical composition
AU2002301776A1 (en) Pharmaceutical Composition
AUPN175995A0 (en) Pharmaceutical composition
AUPN674495A0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted